PDF
Summary of NACI Statement of January 20, 2023: Guidance on COVID-19 vaccine booster doses: Initial considerations for 2023
Organization: Public Health Agency of Canada (PHAC)Published: 2023
This document provides the summary of the NACI statement of January 20, 2023, guidance on COVID-19 vaccine booster doses, initial considerations for 2023.
Resource Group:
Implementation Tool
Product Type: Guide
Program Delivery and Evaluation
Clinics
Vaccine Management
Storage and Handling
Vaccine Safety and Development
Research and Development
Vaccine Effectiveness and Efficacy
Monitoring and Surveillance
Outbreaks and Pandemics
COVID-19
Product Type: Guide
Category:
Program Planning and Delivery,Program Delivery and Evaluation,Clinics,Vaccine Management,Storage and Handling,Vaccine Safety and Development,Research and Development,Vaccine Effectiveness and Efficacy,Monitoring and Surveillance,Outbreaks and Pandemics,COVID-19 Program Planning and DeliveryProgram Delivery and Evaluation
Clinics
Vaccine Management
Storage and Handling
Vaccine Safety and Development
Research and Development
Vaccine Effectiveness and Efficacy
Monitoring and Surveillance
Outbreaks and Pandemics
COVID-19
Language:
English
Audio
LinkResource Rating Breakdown
Ratings submitted by CANVax users for this resource are tallied to provide an average resource rating per category.
0 Comments
Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.
All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.
You must login or register before you can submit a comment.